AmMax Bio Announces Positive Interim Phase 2 Results of AMB-05X for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition